Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy
2025 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-024-55665-1
A
Alberto Contreras‐Sanz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
503
Citations
11
h-index
12
i10-index
Alberto Contreras‐Sanz is an academic researcher from University of British Columbia. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Epigenetics and DNA Methylation & Urinary and Genital Oncology Studies. The author has an h-index of 11, co-authored 51 publications.
ORCID: 0009-0004-9315-6238Papers by this author
worksCancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine
2022 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-022-12528-3
PD12-06 THE IMPACT OF URINARY MICROBIOTA COMPOSITION ON IMMUNE AND INFLAMMATORY RESPONSES IN A HEALTHY MOUSE MODEL
2024 · The Journal of Urology · 0 citations
https://doi.org/10.1097/01.ju.0001008772.30001.48.06
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat